What this means
This is a clinical trial that has not reported results yet, so no findings are available. It describes goals to screen people, find early risk factors for heart, brain, and cancer diseases, and follow high-risk people over time.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 30–80
- Where
- 1 site
The science
- Registered title
- Whole-life Investigation of Lishui Longevity
- Trial ID
- NCT07592962 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Ischemic Stroke, Chronic Disease, Cardiovascular
- Sponsor
- The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital
- Ages
- 30 Years to 80 Years
- Dates
- First posted May 18, 2026 · updated May 18, 2026
Registry summary
- To establish a standardized, normalized and scientific joint screening and follow-up management system for chronic disease multimorbidity in Lishui City, and early identify common risk factors of major chronic diseases such as cardiovascular and cerebrovascular diseases and tumors.
- To carry out targeted intervention and long-term follow-up for high-risk populations, reduce the incidence risk of major chronic diseases in the target population, improve residents' health status and grassroots comprehensive prevention and treatment capacity of chronic diseases, and provide scientific evidence and practical support for the construction of Healthy Lishui.
Sites (1)
- Lishui Central Hospital, Lishui, Zhejiang, China